Emcure Pharmaceuticals Limited (NSE:EMCURE)
1,594.00
-58.70 (-3.55%)
Mar 30, 2026, 3:30 PM IST
48.64% (1Y)
| Market Cap | 302.49B +62.9% |
| Revenue (ttm) | 88.50B +17.2% |
| Net Income | 8.70B +43.2% |
| EPS | 45.90 +39.7% |
| Shares Out | 189.59M |
| PE Ratio | 34.76 |
| Forward PE | 27.50 |
| Dividend | 3.00 (0.18%) |
| Ex-Dividend Date | n/a |
| Volume | 275,305 |
| Average Volume | 401,293 |
| Open | 1,654.90 |
| Previous Close | 1,652.70 |
| Day's Range | 1,584.20 - 1,662.00 |
| 52-Week Range | 889.00 - 1,671.80 |
| Beta | n/a |
| RSI | 59.12 |
| Earnings Date | May 22, 2026 |